Association between inherited deficiencies of the complement components and immune complex disease indicates the importance of the complement system in the handling of circulating immune complexes. High levels of circulating immune complexes are seen in pulmonary tuberculosis. This study is, therefore, aimed to look at the concentration of circulating immune complexes, the status of complement-mediated immune complex handling, and the extent of complement activation in untreated pulmonary tuberculosis compared to treated pulmonary tuberculosis patients and healthy controls.
High immune complex levels, decreased complement-mediated solubilization, and increased activation of the complement system were observed in untreated tuberculosis patients.
The results obtained from the present study suggest that complement mediated solubilization is less in patients with tuberculosis, and this defective solubilization is likely to take part in a vicious cycle involving immune complex deposition and complement activation and, thus, may lead to disease progression depending on the nature of the defect.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Circulating immune complexes
Solubilization of immune complexes
Prevention of Immune precipitation
Complement receptor one
Whaley K, Ahmed AE. Control of immune complexes by the classical pathway. Behring Inst Mitt. 1989;84:111–20.
Bottger EC, Hoffmann T, Hadding U, Bitter-Suermann D. Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease. J Clin Invest. 1986;78:689–95.
Miller GW, Nussenzweig V. A new complement function: solubilization of antigen-antibody aggregates. Proc Natl Acad Sci U S A. 1975;72:418–22.
Schifferli JA, Bartolotti SR, Peters DK. Inhibition of immune precipitation by complement. Clin Exp Immunol. 1980;42:387–94.
May JJ, Katilus J, Henson PM, Dreisin RB. The purification and identification of circulating immune complexes in tuberculosis. Am Rev Respir Dis. 1983;128:920–5.
Ramanathan VD, Parkash O, Ramu G, Parker D, Curtis J, Sengupta U, et al. Isolation and analysis of circulating immune complexes in leprosy. Clin Immunol Immunopathol. 1984;32:261–8.
Yoshinoya S, Cox RA, Pope RM. Circulating immune complexes in coccidioidomycosis. Detection and characterization. J Clin Invest. 1980;66:655–63.
Wemambu SN, Turk JL, Waters MF, Rees RJ. Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet. 1969;2:933–5.
Ramanathan VD, Tyagi P, Ramanathan U, Katoch K, Ramu G. A sequential study of circulating immune complexes, complement and immunoglobulins in borderline tuberculoid leprosy patients with and without reactions. Indian J Lepr. 1998;70:153–60.
Triolo G, Giardina E, Casiglia D, Scarantino G, Bompiani GD. Detection of the terminal fluid-phase complement complex, SC5b–9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor. Clin Exp Immunol. 1991;84:53–8.
Arason GJ, D'Ambrogio MS, Vikingsdottir T, Sigfusson A, Valdimarsson H. Enzyme immunoassays for measuring complement-dependent prevention of immune precipitation (PIP) and solubilization of preformed antigen-antibody complexes (SOL). J Immunol Methods. 1999;223:37–46.
Ramanathan VD, Parkash O, Tyagi P, Sengupta U, Ramu G. Activation of the human complement system by phenolic glycolipid 1 of Mycobacterium leprae. Microb Pathog. 1990;8:403–10.
Ramanathan VD, Sharma P, Ramu G, Sengupta U. Reduced complement-mediated immune complex solubilization in leprosy patients. Clin Exp Immunol. 1985;60:553–8.
Ramanathan VD, Tyagi P, Ramanathan U, Katoch K, Sengupta U, Ramu G. Persistent reduced solubilization of immune complexes in lepromatous leprosy patients with reactions. Int J Lepr Other Mycobact Dis. 1991;59:5–11.
Senbagavalli P, Geetha ST, Karunakaran K, Banu Rekha VV, Venkatesan P, Ramanathan VD. Reduced erythrocyte CR1 levels in patients with pulmonary tuberculosis is an acquired phenomenon. Clin Immunol. 2008;128:109–15.
Seth P, Srinivas R. CIC in cervical cancer. Simple method for detection and characterization. IJMR. 1981;73:926–9.
Tyagi P, Ramanathan VD, Girdhar BK, Katoch K, Bhatia AS, Sengupta U. Activation of complement by circulating immune complexes isolated from leprosy patients. Int J Lepr Other Mycobact Dis. 1990;58:31–8.
S. Nambirajan and K. Chandran provided valuable technical assistance. Financial assistance provided in the form of research fellowship to Senbagavalli by the Indian Council of Medical Research is gratefully acknowledged.
About this article
Cite this article
Senbagavalli, P., Geetha, S.T., Venkatesan, P. et al. Defective Solubilization of Immune Complexes and Activation of the Complement System in Patients with Pulmonary Tuberculosis. J Clin Immunol 29, 674–680 (2009). https://doi.org/10.1007/s10875-009-9301-0
- Circulating immune complexes
- pulmonary tuberculosis
- the complement system
- solubilization of immune complexes
- complement activation fragments
- prevention of immune complex precipitation